Clinical Cancer Research Unit

The Clinical Cancer Research Unit (CRU) at Oslo University Hospital, is the leading center for clinical trials phase I/II in Norway, and is one of the few in Scandinavia that has the expertise and resources to conduct trials of new cancer therapies being tested for the first time in humans. The CRU performs clinical trials of conventional cytotoxic substances to immunotherapy and gene therapy

Our goal is to conduct high quality research for the benefit of current and future patients

More information about the Clinical Cancer Research Unit

Clinical Cancer Research Unit is part of
the Nordic Network for Early Cancer Trials (Nordic NECT)

 
Page visits: 4195